Halozyme to Participate at Upcoming Investor Conferences
Details on the Company's participation are as follows:
Event: |
|
|
|
2025 |
Format: |
|
|
|
Fireside Chat and 1x1 Meetings |
Presentation Date: |
|
|
|
|
Presentation Time: |
|
|
|
|
Location: |
|
|
|
|
|
|
|
|
|
Event: |
|
|
|
Morgan Stanley 23rd Annual Global Healthcare Conference |
Format: |
|
|
|
Fireside Chat and 1x1 Meetings |
Date: |
|
|
|
|
Presentation Time: |
|
|
|
|
Location: |
|
|
|
|
Event: |
|
|
|
|
Format: |
|
|
|
1x1 Meetings |
Date: |
|
|
|
|
Location: |
|
|
|
|
A live audio webcast of the presentations will be available in the Investor Relations section of the Company's website. Replays of the audio webcasts will be available for 90 days following the conference.
About
For more information visit www.halozyme.com and connect with us on LinkedIn and Twitter.
Contacts:
Tram Bui
VP, Investor Relations and Corporate Communications
609-359-3016
tbui@halozyme.com
Teneo
917-972-8407
sydney.charlton@teneo.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/halozyme-to-participate-at-upcoming-investor-conferences-302540470.html
SOURCE